Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Loxl4
REST API REST API
Mus musculus
Loxl4 is differentially expressed in 125 experiments: 46 organism parts: liver, spleen, ... (44 more);, 9 disease states: 3-NP-induced neurodegeneration model of Huntington's disease, EL-4 tumor-bearing, ... (7 more);, 32 cell types 25 cell lines 24 compound treatments and 32 other conditions.
Orthologs LOXL4_BOVIN (Bos taurus)   Loxl4 (Rattus norvegicus)   ENSCING00000006336 (Ciona intestinalis)   LOXL4 (Homo sapiens)   LOXL4 (Gallus gallus)   lox2 (Drosophila melanogaster)   loxl4 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term oxidoreductase activity, protein binding, scavenger receptor activity, extracellular space, membrane, metal ion binding, extracellular region, oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor, protein-lysine 6-oxidase activity, copper ion binding, oxidation-reduction process
InterPro Term Lysyl_oxidase, Srcr_rcpt, Srcr_rcpt-rel
Search EB-eye ENSMUSG00000025185
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-22616, E-TABM-865, E-GEOD-21927, E-MTAB-25, ... (23 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17112, E-GEOD-21515, E-GEOD-19732, E-GEOD-10246, E-MEXP-2554, ... (6 experiments)

Factor Value U/D Experiments
Swiss19
1
E-GEOD-19732
Bruce4_p13
1
E-GEOD-10246
colon cancer (colon26)
1
E-GEOD-17112
67NR
1
E-GEOD-11259
Swiss2
1
E-GEOD-19732
neuro2a
1
E-GEOD-10246
19 more value(s).


Cell type

studied in E-GEOD-19401, E-GEOD-7069, E-GEOD-2433, E-GEOD-21749, E-TABM-130, ... (17 experiments)

Factor Value U/D Experiments
metaphase II oocyte
1
E-MEXP-1146
plasma B cell
1
E-GEOD-4142
type A spermatogonia
1
E-GEOD-4193
memory B cell
1
E-GEOD-4142
LGMP derived from Hoxa9/Meis1a transduced GMP
1
1
E-GEOD-20377
megakaryocyte
1
E-GEOD-2433
26 more value(s).


Disease state

studied in E-GEOD-21927, E-GEOD-10246, E-GEOD-3583, E-GEOD-1871, E-GEOD-15904 ... (5 experiments)

Factor Value U/D Experiments
EL-4 tumor-bearing
1
1
E-GEOD-21927
reference
1
E-GEOD-1871
normal
1
E-GEOD-3583
MMTV-Neu
1
1
E-GEOD-15904
LPS-induced acute lung injury
1
E-GEOD-1871
MMTV-Myc
1
E-GEOD-15904
3 more value(s).


Compound treatment

studied in E-GEOD-21927, E-TABM-903, E-GEOD-21361, E-MEXP-2209, E-MEXP-1276, ... (15 experiments)

Factor Value U/D Experiments
none
1
3
E-GEOD-21927, E-GEOD-5304, E-MEXP-1276, E-MEXP-703
cardiotoxin
2
E-GEOD-5304, E-MEXP-703
control
1
2
E-GEOD-7694, E-TABM-903, E-GEOD-21361
2,3-benzofuran
2
1
E-GEOD-5128
HBSS
1
E-GEOD-18707
Doxycycline
1
1
E-GEOD-21361
18 more value(s).


Amount to core

studied in E-GEOD-18858

Factor Value U/D Experiments
50
1
E-GEOD-18858
15
1
E-GEOD-18858


Clinical info
studied in E-MEXP-1458

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-6290, E-GEOD-7342, E-GEOD-5305, E-GEOD-1749, E-TABM-412, ... (7 experiments)

Disease staging
studied in E-GEOD-17112

dose or concentration
studied in E-GEOD-18858

Generation
studied in E-GEOD-6527

Genotype
studied in E-GEOD-3822, E-GEOD-20335, E-MEXP-1649, E-GEOD-2746, E-TABM-285, ... (21 experiments)

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-GEOD-20302, E-GEOD-2973

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Irradiate
studied in E-GEOD-4066

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-5296

Phenotype
studied in E-GEOD-2640, E-GEOD-19979

Ratio
studied in E-GEOD-18858

Rna integrity number
studied in E-GEOD-18858

Route of exposure
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15901

Strain or line
studied in E-TABM-865, E-GEOD-21515, E-GEOD-21278, E-MTAB-76, E-TABM-285, ... (8 experiments)

Treatment
studied in E-GEOD-18344, E-GEOD-21841, E-MEXP-1899, E-GEOD-13388, E-MEXP-2189 ... (5 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of amount of vehicle
studied in E-GEOD-18858

units of dose or concentration
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.161 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM